Product Description
Indications
The indication for use is hemorrhoidal disease.
The medicinal product is indicated for use in adults.
Dosage
Dosage
Adults: Unless your doctor recommends otherwise, apply the gel to the affected area using the enclosed cannula or press approximately 0.5 - 1.0 g (a strip of gel approximately 2 cm long) into the rectum, 2 - 3 times a day, until the acute symptoms subside. Then the dose can be reduced to apply the gel once a day. The preparation should be used until the symptoms disappear.
If there is no improvement after 7 days of use, or if the symptoms associated with hemorrhoidal disease worsen, contact your doctor.
Method of administration
Rectal administration.
Wash your hands after each use of the product.
The safety of the medicinal product in children has not been established. Therefore, it is not recommended for use in persons under 18 years of age.
Adverse reactions
No adverse reactions to Neo-Aesculan gel have been reported so far. Local use of preparations containing lidocaine may occasionally cause an allergic reaction, and rarely anaphylactic shock. Balsam of Peru, chamomile oil, and ethyl parahydroxybenzoate may cause an allergic reaction (may be delayed). Bronopol may cause local skin irritation (contact dermatitis).
Contraindications
Neo-Aesculan should not be used if you are hypersensitive to the active substances or to any of the excipients listed in section 6.1, allergic to amide local anesthetics and/or to plants of the Asteraceae family.
Precautions
If severe rectal bleeding, blood in the stools, or severe pain occurs, consult a doctor.
Interactions
Concurrent rectal administration of other local anesthetics is not recommended.
There is a theoretical risk of enhancing the effect of anticoagulants with concomitant use of horse chestnut extract. There is no direct experimental or clinical evidence. It is recommended that patients using horse chestnut extract concomitantly with anticoagulants, e.g., warfarin, closely monitor their symptoms to detect possible signs of increased bleeding. There are no reports of clinical cases.
Pregnancy
No controlled clinical trials have been performed in pregnant or lactating women. Therefore, the use of the medicinal product during this period is not recommended.
Driving
There are no data on the effect of the use of Neo-Aesculan on the ability to drive and operate machinery.
Overdose
No data available.
Notes
International name/composition: Hippocastani corticis extractum siccum + Lidocaini hydrochloridum. Dose: (50mg + 5mg)/g
Comment